Ryan Specialty Group (RYAN) Reports In-Line Q3 EPS, provides outlook

Ryan Specialty Group (NYSE: RYAN) reported Q3 EPS of $0.41, in-line with the analyst estimate of $0.41. Revenue for the quarter came in at $604.7 million versus the consensus estimate of $602.04 million.

Full Year 2024 Outlook

The Company is maintaining its full year 2024 outlook for Organic Revenue Growth Rate and Adjusted EBITDAC Margin as follows:

Organic Revenue Growth Rate guidance for full year 2024 is between 13.0% – 14.0%

Adjusted EBITDAC Margin guidance for full year 2024 is between 32.0% – 32.5%

For earnings history and earnings-related data on Ryan Specialty Group (RYAN) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Pan American Silver (PAAS) Misses Q2 EPS by 19c